Haas M - Search Results

1

Is it Time for a Molecular-based Classification System for Sinonasal Squamous Cell Carcinoma?

Haas M, Hansen EE, Lewis JS Jr, Faden DL. Haas M, et al. Am J Surg Pathol. 2022 Jul 1;46(7):873-877. doi: 10.1097/PAS.0000000000001871. Epub 2022 Feb 8. Am J Surg Pathol. 2022. PMID: 35131987 No abstract available.

2

circulating tumor DNA in the immediate post-operative setting.

Efthymiou V, Queenan N, Haas M, Naegele S, Goss D, Faden DL. Efthymiou V, et al. Among authors: haas m. medRxiv [Preprint]. 2023 Oct 2:2023.09.30.23296390. doi: 10.1101/2023.09.30.23296390. medRxiv. 2023. PMID: 37873394 Free PMC article. Updated. Preprint.

3

Circulating Tumor DNA in the Immediate Postoperative Setting.

Efthymiou V, Queenan N, Haas M, Naegele S, Goss D, Faden DL. Efthymiou V, et al. Among authors: haas m. Ann Surg Oncol. 2024 Apr;31(4):2319-2325. doi: 10.1245/s10434-023-14860-y. Epub 2024 Jan 8. Ann Surg Oncol. 2024. PMID: 38190058 Review.

4

[No title available]

[No authors listed] [No authors listed] PMID: 38316733

5

Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro.

Jank BJ, Lenz T, Haas M, Kadletz-Wanke L, Campion NJ, Schnoell J, Heiduschka G, Macfelda K. Jank BJ, et al. Among authors: haas m. Invest New Drugs. 2022 Jun;40(3):478-486. doi: 10.1007/s10637-021-01207-1. Epub 2022 Jan 5. Invest New Drugs. 2022. PMID: 34985593 Free PMC article.

6

The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer.

Haas M, Lein A, Fuereder T, Brkic FF, Schnoell J, Liu DT, Kadletz-Wanke L, Heiduschka G, Jank BJ. Haas M, et al. Nutrients. 2023 Feb 9;15(4):880. doi: 10.3390/nu15040880. Nutrients. 2023. PMID: 36839241 Free PMC article.

7

Targeting TGF beta receptor 1 in head and neck squamous cell carcinoma.

Jank BJ, Schnoell J, Kladnik K, Sparr C, Haas M, Gurnhofer E, Lein AL, Brunner M, Kenner L, Kadletz-Wanke L, Heiduschka G. Jank BJ, et al. Among authors: haas m. Oral Dis. 2024 Apr;30(3):1114-1127. doi: 10.1111/odi.14594. Epub 2023 May 8. Oral Dis. 2024. PMID: 37154295

8

Epithelial stem cell marker LGR6 expression identifies a low-risk subgroup in human papillomavirus positive oropharyngeal squamous cell carcinoma.

Jank BJ, Kadletz L, Dunkler D, Haas M, Schnoell J, Kenner L, Heiduschka G. Jank BJ, et al. Among authors: haas m. Oral Oncol. 2020 Jun;105:104657. doi: 10.1016/j.oraloncology.2020.104657. Epub 2020 Mar 31. Oral Oncol. 2020. PMID: 32244172

9

µ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma.

Jank BJ, Haas M, Schnoell J, Schlederer M, Heiduschka G, Kenner L, Kadletz-Wanke L. Jank BJ, et al. Among authors: haas m. J Pers Med. 2021 Dec 8;11(12):1330. doi: 10.3390/jpm11121330. J Pers Med. 2021. PMID: 34945802 Free PMC article.

10

Inhibition of beta-catenin shows therapeutic potential in head and neck squamous cell carcinoma in vitro.

Maier T, Stoiber S, Gurnhofer E, Haas M, Kenner L, Heiduschka G, Kadletz-Wanke L, Brkic FF. Maier T, et al. Among authors: haas m. Eur Arch Otorhinolaryngol. 2023 Jan;280(1):399-408. doi: 10.1007/s00405-022-07598-y. Epub 2022 Aug 24. Eur Arch Otorhinolaryngol. 2023. PMID: 36001136 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,057 results

Search Page